Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-30

Clinical Trial Update: Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease

View source ↗

Summary

A completed Rush University Medical Center clinical trial investigates increased gut permeability to lipopolysaccharides in Parkinson's disease, with multiple s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rush University Medical Center | Conditions: Parkinson's Disease, Multiple System Atrophy | Status: COMPLETED